PhD ceremony: Mr. K.K. Katta, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Role of proteoglycans in renal chronic transplant dysfunction
Promotor(s): prof. G.J. Navis, prof. J.L. Hillebrands
Faculty: Medical Sciences
Kidney transplantation is the best treatment for patients with end stage renal failure, in terms of quality of life and life expectancy. Chronic transplant dysfunction (CTD) is associated with decline in kidney function over time and is related to progressive tissue remodeling in the transplanted kidney. Proteoglycans (PGs) have been highly implicated in tissue remodeling such as development, adhesion, migration, growth, wound healing and repair processes, proliferation and fibrosis. This implies that targeting proteoglycan function might provide a strategy to combat CTD-associated tissue remodeling. The data presented in this thesis show the involvement of PGs in CTD tissue remodeling. We showed an upregulation of the heparan sulfate PGs collagen type XVIII and perlecan and chondroitin sulfate PG versican in rat renal allografts. The binding properties of the upregulated PGs has increased upon renal allotransplantation. Perlecan and FGF2 were found to be upregulated in renal allografts. The functional and mechanistical roles of these PGs were studied in vitro using rat glomerular mesangial cells. The results showed that PGs mediated FGF2-dependent proliferation of mesangial cells. Treatment with non-anti-coagulant heparin (RO-heparin) showed beneficial effects after rat renal transplantation. Considering the molecular mechanisms behind neointima formation, we showed that in response to allogeneic transplantation there will be medial dedifferentiation, probably mediated by PDGF-B. Lastly we showed that syndecan-1, a trans-membrane cell surface heparan sulfate PG, is involved in tubular regeneration and repair after renal transplantation and ischemia/reperfusion which correlated with better graft function and survival. Overall PGs are crucially involved in tissue remodeling after transplantation and promising intervention molecules to retard CTD.
Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...
Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...
Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether you want to accept
or reject other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information